High Dose Vitamin D, “Significantly Reduced the Need for ICU Treatment of Patients Requiring Hospitalization Due to Proven COVID-19”
September 3rd, 2020Via: The Journal of Steroid Biochemistry and Molecular Biology:
Our pilot study demonstrated that administration of a high dose of Calcifediol or 25-hydroxyvitamin D, a main metabolite of vitamin D endocrine system, significantly reduced the need for ICU treatment of patients requiring hospitalization due to proven COVID-19. Calcifediol seems to be able to reduce severity of the disease, but larger trials with groups properly matched will be required to show a definitive answer.
